Multi-targeting Drug DREAM Challenge
Learn More Polypharmacology has key advantages for a host of diseases including cancer, diabetes, and Mendelian diseases. Recent data supports the view
Learn More Polypharmacology has key advantages for a host of diseases including cancer, diabetes, and Mendelian diseases. Recent data supports the view
Learn More Transcription factors (TFs) are regulatory proteins that bind specific sequence motifs in the genome to activate or repress transcription of
Learn More Recent advances in mobile health have demonstrated great potential to leverage sensor-based technologies for quantitative, remote monitoring of health and
Learn More The highly distributed and disparate nature of genomic and clinical data generated around the world presents an enormous challenge for
Learn More Cancer is driven by aberrations in the genome [1,2], and these alterations manifest themselves largely in the changes in the
Learn More The Digital Mammography DREAM Challenge will attempt to improve the predictive accuracy of digital mammography for the early detection of
Learn More Multiple myeloma (MM) is a cancer of the plasma cells in the bone marrow, and its clinical course depends on
Learn More The ICGC-TCGA DREAM Somatic Mutation Calling - RNA Challenge (SMC-RNA) is an international effort to improve standard methods for identifying
Learn More Physiological and disease processes are typically not driven by a single gene, but multiple genes that interact within molecular modules
Learn More Respiratory viruses are highly infectious and cause acute illness in millions of people every year. However, there is wide variation